Evidence for the involvement of dopamine in ambulation promoted by menthol in mice

Journal Pharmacological Sciences

Volumn 91, Issue 2, 2003, Pages 125-135

  Umezu, Toyoshi ^a   Morita, Masatoshi ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Ambulation; Dopamine agonist; Dopamine antagonist; Menthol

Indexed keywords

1 PHENYL 2,3,4,5 TETRAHYDRO 1H 7,8 DIMETHOXY 3 BENZAZEPINE; AMFEBUTAMONE; CHLORPROMAZINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; FLUPHENAZINE; HALOPERIDOL; MENTHOL; METIROSINE; MONOAMINE; PEPPERMINT OIL; RESERPINE; SPIPERONE; TREPIPAM MALEATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; EVIDENCE BASED MEDICINE; MALE; MOBILIZATION; MOUSE; NONHUMAN; PHYSICAL ACTIVITY;

EID: 0038702310     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.91.125     Document Type: Article

References (32)

1. Balchin ML: Essential oils and 'aromatherapy': Their modern role in healing. J R Soc Health 117, 324-329 (1997)
2. Buckle J: Use of aromatherapy as a complementary treatment of chronic pain. Altern Ther 5, 42-51 (1999)
3. Umezu T: Anticonflict effects of plant-derived essential oils. Pharmacol Biochem Behav 64, 35-40 (1999)
4. Umezu T: Behavioral effects of plant-derived essential oils in the Geller type conflict test in mice. Jpn J Pharmacol 83, 150-153
5. Umezu T, Sakata A and Ito H: Ambulation-promoting effect of peppermit oil and identification of its active constituents. Pharmacol Biochem Behav 69, 383-390 (2001)
6. Tisserand R: The Art of Aromatherapy. CW Daniel Company Ltd, Essex, UK (1993)
7. Kuribara H and Tadokoro S: Circadian variation in the ambulation-increasing effect of apomorphine after repeated administration in mice. Jpn J Psychopharmacol 4, 231-236 (1984)
8. Hirate K and Kuribara H: Characteristics of ambulation-increasing effect of GBR-12909, a selective dopamine uptake inhibitor, in mice. Jpn J Pharmacol 55, 501-511 (1991)
9. Asami T, Kuribara H and Tadokoro S: Effects of repeated administration of bromocryptine on ambulatory activity in mice. Jpn J Psychopharmacol 6, 309-317 (1986)
10. Kuribara H and Uchihashi Y: Dopamine antagonists inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J Pharm Pharmacol 45, 1042-1045 (1993)
11. Kuribara H and Uchihashi Y: Effects of haloperidol on the methamphetamine sensitization: Assessment by ambulatory activity in mice. Jpn J Psychiatr Neurol 47, 661-668 (1993)
12. Kuribara H: Can posttreatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice. Pharmacol Biochem Behav 49, 323-326 (1994)
13. Kuribara H: Dopamine D1 and D2 receptor antagonists suppress acute stimulant action of cocaine, but enhance cocaine sensitization. Jpn J Psychiatr Neurol 48, 907-911 (1994)
14. Kuribara H and Uchihashi Y: Effects of dopamine antagonism on methamphetamine sensitization: Evaluation by ambulatory activity in mice. Pharmacol Biochem Behav 47, 101-106 (1994)
15. Kuribara H: Effects of sulpiride and nemonapride, benzamide derivatives having distinct potencies of antagonistic action on dopamide D2 receptors, on sensitization to methamphetamine in mice. J Pharm Pharmacol 48, 292-296 (1995)
16. Kuribara H: Interaction between D1 and D2 antagonists in the inhibition of methamphetamine-induced ambulation in mice. Pharmaceutical Sci 2, 141-144 (1996)
17. Kuribara H, Asami T, Ida I and Tadokoro S: Characteristics of the ambulation-increasing effect of the non-competitive NMDA antagonist MK-801 in mice: Assessment by the coadministration with central-acting drugs. Jpn J Pharmacol 50, 11-18 (1992)
18. Kuribara H: Modification of morphine sensitization by opioid and dopamine receptor antagonists: Evaluation by studying ambulation in mice. Eur J Pharmacol 275, 251-258 (1995)
19. Munzar P and Goldberg SR: Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 148, 209-216 (2000)
20. Gazzara RA and Andersen SL: The effects of bupropion in vivo in the neostriatum of 5-day-old and adult rats. Brain Res Dev Brain Res 100, 139-142 (1997)
21. Umezu T, Yonemoto J, Soma Y and Suzuki T: Tris(2-choloroethyl)phosphate increases ambulatory activity in mice. Pharmacological analyses of its neurochemical mechanism. Toxicol Appl Pharmacol 148, 109-116 (1998)
22. Hirabayashi H, Iizuka M and Tadokoro S: Simple and easy method for measurement of ambulatory activity in mice. Folia Pharmacol Jpn 74, 629-639 (1978) (text in Japanese with English abstract)
23. Oades RD, Rao ML, Bender S, Sartory G and Muller BW: Neuropsychological and conditioned blocking performance in patients with schizophrenia: Assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy. Behav Pharmacol 11, 317-330 (2000)
24. Kronthaler UO and Schmidt WJ: Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and D2 receptor antagonist-induced hypokinesia in the rat. Naunyn Schmiedebergs Arch Pharmacol 361, 289-297 (2000)
25. 3 receptor knock-out mice. Eur J Pharmacol 391, 63-73 (2000)
26. O'Neill MF, Dourish CT and Iversen SD: Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) 104, 343-350 (1991)
27. Breese GR, Criswell HE, McQuade RD, Iorio LC and Mueller RA: Pharmacological evaluation of SCH12679: Evidence for an in vivo antagonism of D1 dopamine receptors. J Pharmacol Exp Ther 252, 558-567 (1990)
28. Silva RH, Abilio VC, Torres-Leite D, Bergamo M, Chinen CC, Claro FT, Carvalho Rde C and Frussa-Filho R: Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice. Behav Brain Res 14, 171-177 (2002)
29. Matsuda H, Li Y and Yoshikawa M: Possible involvement of dopamine and dopamine 2 receptors in the inhibition of gastric emptying in mice. Life Sci 67, 2921-2927 (2000)
30. Yavich L and Macdonald E: Dopamine release from pharmacologically distinct storage in rat striatum following stimulation at frequency of neuronal bursting. Brain Res 870, 73-79 (2000)
31. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Early TJ, Dragoni I, McIntyre P, Bevan S and Patapoutian A: A TRP channel that senses cold stimuli and menthol. Cell 108, 705-715 (2002)
32. McKemy DD, Neuhausser WM and Julius D: Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416, 52-58 (2002)